Medscape
- Medscape ( Middle East ) 2025/6/3
Rigosertib shows promise for treating advanced squamous cell cancer in patients with recessive dystrophic epidermolysis bullosa, according t...
- Medscape ( Middle East ) 2025/6/3
Even years later, patients whose symptoms were initially dismissed experience distrust and uncertainty with clinicians. Medscape Medical...
- Medscape ( Middle East ) 2025/6/2
Almost all UK pharmacies have reported difficulties obtaining vital pancreatic enzyme therapy as patients skip meals to ration supplies....
- Medscape ( Middle East ) 2025/6/2
A new algorithm, tested via computer modeling across the continental United States, more accurately routes patients with stroke to EVT cente...
- Medscape ( Middle East ) 2025/6/2
Cefazolin is safe for surgical site infection prophylaxis in orthopedic procedures for patients with beta-lactam allergies, a new study show...
- Medscape ( Middle East ) 2025/6/2
A novel generative AI framework can predict the need for red blood cell transfusion and mortality risk in ICU patients with acute GI bleedin...
- Medscape ( Middle East ) 2025/6/2
A supervised, home-based exercise program for patients with MS delivered short- and long-term benefits comparable to those of a facility-bas...
- Medscape ( Middle East ) 2025/6/2
In a national briefing, health professionals talk about fear, prevention, and the limits of just-the-facts strategies. Medscape Medical N...
- Medscape ( Middle East ) 2025/6/2
The prevalence of gene variants linked to cardiomyopathy is markedly higher in patients with AF, and particularly those with early-onset AF,...
- Medscape ( Middle East ) 2025/6/2
Exploring a career in urology? Gain valuable insights into the daily practice and professional responsibilities of a urological specialist....
- Medscape ( Middle East ) 2025/6/2
In a head-to-head trial, telemedicine-based neurologist assessments in mobile stroke units is safer and more resource-efficient than traditi...
- Medscape ( Middle East ) 2025/6/2
A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic dysfunction–assoc...
- Medscape ( Middle East ) 2025/6/2
Among older adults with dementia, the use of home healthcare increased from 2010 to 2019 but dropped after 2020, signaling concerns for this...
- Medscape ( Middle East ) 2025/6/2
Research is evaluating chronotherapy to target drugs to reduce morning stiffness and flares in rheumatoid arthritis, but it has a long way t...
- Medscape ( Middle East ) 2025/6/2
A novel triple reuptake inhibitor is efficacious and ‘clinically meaningful’ for adult attention-deficit/hyperactivity disorder, combined re...
- Medscape ( Middle East ) 2025/6/2
The manufacturer has discontinued ACURATE neo2 and PRIME valves after a study found neo2 leads to worse outcomes than other commercially ava...
- Medscape ( Middle East ) 2025/6/2
Long-term control of cardiovascular risk factors and sustained clinical remission help to mitigate the higher risk for atherosclerosis progr...
- Medscape ( Middle East ) 2025/6/2
When performed appropriately, same-day discharge ablation of atrial fibrillation is encouraged, according to joint statement from the Americ...
- Medscape ( Middle East ) 2025/6/2
Counselors bridge the gap between diagnosis and support, reducing patient anxiety and improving outcomes. Medscape Medical News
- Medscape ( Middle East ) 2025/6/2
TTFields offers “a potential treatment advance” in pancreatic cancer, a new study finds. Medscape Medical News
- Medscape ( Middle East ) 2025/6/1
New data show improved outcomes in resectable pancreatic cancer with PAXG chemotherapy over standard mFOLFIRINOX, but should PAXG replace mF...
- Medscape ( Middle East ) 2025/6/1
Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However, clinical tria...
- Medscape ( Middle East ) 2025/6/1
Vepdegestrant outshines fulvestrant in advanced or metastatic ER+/HER2- breast cancer. Medscape Medical News
- Medscape ( Middle East ) 2025/6/1
Claudin 18 isoform 2–targeted chimeric antigen receptor T-cell therapy significantly prolongs time to disease progression in patients with r...
- Medscape ( Middle East ) 2025/5/31
Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ponatinib later can a...